Elanco Animal Health Inc financial data

Symbol
ELAN on NYSE
Industry
Pharmaceutical Preparations
Location
2500 Innovation Way, Greenfield, IN
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 25, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 280 % +5.88%
Quick Ratio 123 % -1.42%
Debt-to-equity 118 % -2.53%
Return On Equity 5.49 %
Return On Assets 2.52 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 495M shares +0.09%
Common Stock, Shares, Outstanding 494M shares +0.33%
Entity Public Float 7.1B USD +44.9%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 494M shares +0.35%
Weighted Average Number of Shares Outstanding, Diluted 497M shares +1.02%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 4.44B USD +0.5%
Research and Development Expense 344M USD +5.2%
Costs and Expenses 3.95B USD -29.6%
Nonoperating Income (Expense) -46M USD +25.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 488M USD +59.8%
Income Tax Expense (Benefit) 150M USD +317%
Net Income (Loss) Attributable to Parent 338M USD +94.3%
Earnings Per Share, Basic 0.68 USD/shares +93.1%
Earnings Per Share, Diluted 0.68 USD/shares +96.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 468M USD +33%
Accounts Receivable, after Allowance for Credit Loss, Current 805M USD -4.39%
Inventory, Net 1.57B USD -9.28%
Assets, Current 3.22B USD -5.64%
Property, Plant and Equipment, Net 993M USD -3.22%
Operating Lease, Right-of-Use Asset 122M USD -12.9%
Intangible Assets, Net (Excluding Goodwill) 3.68B USD -18.1%
Goodwill 4.41B USD -13.3%
Other Assets, Noncurrent 311M USD -8.8%
Assets 12.6B USD -12.2%
Accounts Payable, Current 296M USD +9.63%
Employee-related Liabilities, Current 177M USD +12.7%
Contract with Customer, Liability, Current 332M USD -9.54%
Liabilities, Current 1.32B USD +5.96%
Deferred Income Tax Liabilities, Net 449M USD -20.8%
Operating Lease, Liability, Noncurrent 92M USD -16.4%
Other Liabilities, Noncurrent 302M USD -26.5%
Liabilities 6.52B USD -19.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -771M USD -190%
Retained Earnings (Accumulated Deficit) -1.95B USD +14.8%
Stockholders' Equity Attributable to Parent 6.1B USD -2.04%
Liabilities and Equity 12.6B USD -12.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2M USD
Net Cash Provided by (Used in) Financing Activities -27M USD -116%
Net Cash Provided by (Used in) Investing Activities 37M USD
Common Stock, Shares Authorized 5B shares 0%
Common Stock, Shares, Issued 494M shares +0.33%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7M USD +74.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 468M USD +33%
Deferred Tax Assets, Valuation Allowance 269M USD -25.9%
Deferred Tax Assets, Gross 689M USD -15.5%
Operating Lease, Liability 123M USD -13.4%
Payments to Acquire Property, Plant, and Equipment 24M USD 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -167M USD +84.9%
Lessee, Operating Lease, Liability, to be Paid 142M USD -13.4%
Property, Plant and Equipment, Gross 1.85B USD +0.54%
Operating Lease, Liability, Current 31M USD -3.13%
Lessee, Operating Lease, Liability, to be Paid, Year Two 30M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 37M USD -5.13%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) 2M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 19M USD -13.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 22M USD -12%
Deferred Tax Assets, Operating Loss Carryforwards 180M USD -42.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1B shares 0%
Unrecognized Tax Benefits 40M USD +29%
Lessee, Operating Lease, Liability, to be Paid, Year Four 13M USD -18.8%
Additional Paid in Capital 8.82B USD +0.46%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 527M USD -3.83%
Depreciation, Depletion and Amortization 166M USD -4.05%
Deferred Tax Assets, Net of Valuation Allowance 420M USD -7.08%
Interest Expense 256M USD -5.88%